APA (7th ed.) Citation

A, C., Z, P., SS, S., J, B., M, L., RJ, S., & CL, M. (2022). The discriminatory ability of FibroScan liver stiffness measurement, controlled attenuation parameter, and FibroScan-aspartate aminotransferase to predict severity of liver disease in children. Hepatology communications, 6(11), 3015. https://doi.org/10.1002/hep4.1983

Chicago Style (17th ed.) Citation

A, Chaidez, Pan Z, Sundaram SS, Boster J, Lovell M, Sokol RJ, and Mack CL. "The Discriminatory Ability of FibroScan Liver Stiffness Measurement, Controlled Attenuation Parameter, and FibroScan-aspartate Aminotransferase to Predict Severity of Liver Disease in Children." Hepatology Communications 6, no. 11 (2022): 3015. https://doi.org/10.1002/hep4.1983.

MLA (9th ed.) Citation

A, Chaidez, et al. "The Discriminatory Ability of FibroScan Liver Stiffness Measurement, Controlled Attenuation Parameter, and FibroScan-aspartate Aminotransferase to Predict Severity of Liver Disease in Children." Hepatology Communications, vol. 6, no. 11, 2022, p. 3015, https://doi.org/10.1002/hep4.1983.